Global Anti-amyloid Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 74

Published Date: 27 Oct 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

According to our (Global Info Research) latest study, the global Anti-amyloid Therapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Anti-amyloid Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Anti-amyloid Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-amyloid Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-amyloid Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-amyloid Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-amyloid Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-amyloid Therapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eisai, Biogen, Eli Lilly, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Anti-amyloid Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Lecanemab
    Donanemab

Market segment by Application
    Hospital
    Clinic
    Other

Major players covered
    Eisai
    Biogen
    Eli Lilly

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-amyloid Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-amyloid Therapy, with price, sales quantity, revenue, and global market share of Anti-amyloid Therapy from 2019 to 2024.
Chapter 3, the Anti-amyloid Therapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-amyloid Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Anti-amyloid Therapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-amyloid Therapy.
Chapter 14 and 15, to describe Anti-amyloid Therapy sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Anti-amyloid Therapy Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Lecanemab
        1.3.3 Donanemab
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Anti-amyloid Therapy Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Anti-amyloid Therapy Market Size & Forecast
        1.5.1 Global Anti-amyloid Therapy Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Anti-amyloid Therapy Sales Quantity (2019-2030)
        1.5.3 Global Anti-amyloid Therapy Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Eisai
        2.1.1 Eisai Details
        2.1.2 Eisai Major Business
        2.1.3 Eisai Anti-amyloid Therapy Product and Services
        2.1.4 Eisai Anti-amyloid Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Eisai Recent Developments/Updates
    2.2 Biogen
        2.2.1 Biogen Details
        2.2.2 Biogen Major Business
        2.2.3 Biogen Anti-amyloid Therapy Product and Services
        2.2.4 Biogen Anti-amyloid Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Biogen Recent Developments/Updates
    2.3 Eli Lilly
        2.3.1 Eli Lilly Details
        2.3.2 Eli Lilly Major Business
        2.3.3 Eli Lilly Anti-amyloid Therapy Product and Services
        2.3.4 Eli Lilly Anti-amyloid Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Eli Lilly Recent Developments/Updates

3 Competitive Environment: Anti-amyloid Therapy by Manufacturer
    3.1 Global Anti-amyloid Therapy Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Anti-amyloid Therapy Revenue by Manufacturer (2019-2024)
    3.3 Global Anti-amyloid Therapy Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Anti-amyloid Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Anti-amyloid Therapy Manufacturer Market Share in 2023
        3.4.3 Top 6 Anti-amyloid Therapy Manufacturer Market Share in 2023
    3.5 Anti-amyloid Therapy Market: Overall Company Footprint Analysis
        3.5.1 Anti-amyloid Therapy Market: Region Footprint
        3.5.2 Anti-amyloid Therapy Market: Company Product Type Footprint
        3.5.3 Anti-amyloid Therapy Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Anti-amyloid Therapy Market Size by Region
        4.1.1 Global Anti-amyloid Therapy Sales Quantity by Region (2019-2030)
        4.1.2 Global Anti-amyloid Therapy Consumption Value by Region (2019-2030)
        4.1.3 Global Anti-amyloid Therapy Average Price by Region (2019-2030)
    4.2 North America Anti-amyloid Therapy Consumption Value (2019-2030)
    4.3 Europe Anti-amyloid Therapy Consumption Value (2019-2030)
    4.4 Asia-Pacific Anti-amyloid Therapy Consumption Value (2019-2030)
    4.5 South America Anti-amyloid Therapy Consumption Value (2019-2030)
    4.6 Middle East & Africa Anti-amyloid Therapy Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    5.2 Global Anti-amyloid Therapy Consumption Value by Type (2019-2030)
    5.3 Global Anti-amyloid Therapy Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    6.2 Global Anti-amyloid Therapy Consumption Value by Application (2019-2030)
    6.3 Global Anti-amyloid Therapy Average Price by Application (2019-2030)

7 North America
    7.1 North America Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    7.2 North America Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    7.3 North America Anti-amyloid Therapy Market Size by Country
        7.3.1 North America Anti-amyloid Therapy Sales Quantity by Country (2019-2030)
        7.3.2 North America Anti-amyloid Therapy Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    8.2 Europe Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    8.3 Europe Anti-amyloid Therapy Market Size by Country
        8.3.1 Europe Anti-amyloid Therapy Sales Quantity by Country (2019-2030)
        8.3.2 Europe Anti-amyloid Therapy Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Anti-amyloid Therapy Market Size by Region
        9.3.1 Asia-Pacific Anti-amyloid Therapy Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Anti-amyloid Therapy Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    10.2 South America Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    10.3 South America Anti-amyloid Therapy Market Size by Country
        10.3.1 South America Anti-amyloid Therapy Sales Quantity by Country (2019-2030)
        10.3.2 South America Anti-amyloid Therapy Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Anti-amyloid Therapy Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Anti-amyloid Therapy Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Anti-amyloid Therapy Market Size by Country
        11.3.1 Middle East & Africa Anti-amyloid Therapy Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Anti-amyloid Therapy Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Anti-amyloid Therapy Market Drivers
    12.2 Anti-amyloid Therapy Market Restraints
    12.3 Anti-amyloid Therapy Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Anti-amyloid Therapy and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Anti-amyloid Therapy
    13.3 Anti-amyloid Therapy Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Anti-amyloid Therapy Typical Distributors
    14.3 Anti-amyloid Therapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Anti-amyloid Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Anti-amyloid Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Eisai Basic Information, Manufacturing Base and Competitors
 Table 4. Eisai Major Business
 Table 5. Eisai Anti-amyloid Therapy Product and Services
 Table 6. Eisai Anti-amyloid Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Eisai Recent Developments/Updates
 Table 8. Biogen Basic Information, Manufacturing Base and Competitors
 Table 9. Biogen Major Business
 Table 10. Biogen Anti-amyloid Therapy Product and Services
 Table 11. Biogen Anti-amyloid Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Biogen Recent Developments/Updates
 Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
 Table 14. Eli Lilly Major Business
 Table 15. Eli Lilly Anti-amyloid Therapy Product and Services
 Table 16. Eli Lilly Anti-amyloid Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Eli Lilly Recent Developments/Updates
 Table 18. Global Anti-amyloid Therapy Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 19. Global Anti-amyloid Therapy Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 20. Global Anti-amyloid Therapy Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Market Position of Manufacturers in Anti-amyloid Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 22. Head Office and Anti-amyloid Therapy Production Site of Key Manufacturer
 Table 23. Anti-amyloid Therapy Market: Company Product Type Footprint
 Table 24. Anti-amyloid Therapy Market: Company Product Application Footprint
 Table 25. Anti-amyloid Therapy New Market Entrants and Barriers to Market Entry
 Table 26. Anti-amyloid Therapy Mergers, Acquisition, Agreements, and Collaborations
 Table 27. Global Anti-amyloid Therapy Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 28. Global Anti-amyloid Therapy Sales Quantity by Region (2019-2024) & (K Units)
 Table 29. Global Anti-amyloid Therapy Sales Quantity by Region (2025-2030) & (K Units)
 Table 30. Global Anti-amyloid Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 31. Global Anti-amyloid Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 32. Global Anti-amyloid Therapy Average Price by Region (2019-2024) & (US$/Unit)
 Table 33. Global Anti-amyloid Therapy Average Price by Region (2025-2030) & (US$/Unit)
 Table 34. Global Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 35. Global Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 36. Global Anti-amyloid Therapy Consumption Value by Type (2019-2024) & (USD Million)
 Table 37. Global Anti-amyloid Therapy Consumption Value by Type (2025-2030) & (USD Million)
 Table 38. Global Anti-amyloid Therapy Average Price by Type (2019-2024) & (US$/Unit)
 Table 39. Global Anti-amyloid Therapy Average Price by Type (2025-2030) & (US$/Unit)
 Table 40. Global Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 41. Global Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 42. Global Anti-amyloid Therapy Consumption Value by Application (2019-2024) & (USD Million)
 Table 43. Global Anti-amyloid Therapy Consumption Value by Application (2025-2030) & (USD Million)
 Table 44. Global Anti-amyloid Therapy Average Price by Application (2019-2024) & (US$/Unit)
 Table 45. Global Anti-amyloid Therapy Average Price by Application (2025-2030) & (US$/Unit)
 Table 46. North America Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 47. North America Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 48. North America Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 49. North America Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 50. North America Anti-amyloid Therapy Sales Quantity by Country (2019-2024) & (K Units)
 Table 51. North America Anti-amyloid Therapy Sales Quantity by Country (2025-2030) & (K Units)
 Table 52. North America Anti-amyloid Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 53. North America Anti-amyloid Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 54. Europe Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 55. Europe Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 56. Europe Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 57. Europe Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 58. Europe Anti-amyloid Therapy Sales Quantity by Country (2019-2024) & (K Units)
 Table 59. Europe Anti-amyloid Therapy Sales Quantity by Country (2025-2030) & (K Units)
 Table 60. Europe Anti-amyloid Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 61. Europe Anti-amyloid Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 62. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 63. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 64. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 65. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 66. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Region (2019-2024) & (K Units)
 Table 67. Asia-Pacific Anti-amyloid Therapy Sales Quantity by Region (2025-2030) & (K Units)
 Table 68. Asia-Pacific Anti-amyloid Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 69. Asia-Pacific Anti-amyloid Therapy Consumption Value by Region (2025-2030) & (USD Million)
 Table 70. South America Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 71. South America Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 72. South America Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 73. South America Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 74. South America Anti-amyloid Therapy Sales Quantity by Country (2019-2024) & (K Units)
 Table 75. South America Anti-amyloid Therapy Sales Quantity by Country (2025-2030) & (K Units)
 Table 76. South America Anti-amyloid Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 77. South America Anti-amyloid Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 78. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Type (2019-2024) & (K Units)
 Table 79. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Type (2025-2030) & (K Units)
 Table 80. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Application (2019-2024) & (K Units)
 Table 81. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Application (2025-2030) & (K Units)
 Table 82. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Country (2019-2024) & (K Units)
 Table 83. Middle East & Africa Anti-amyloid Therapy Sales Quantity by Country (2025-2030) & (K Units)
 Table 84. Middle East & Africa Anti-amyloid Therapy Consumption Value by Country (2019-2024) & (USD Million)
 Table 85. Middle East & Africa Anti-amyloid Therapy Consumption Value by Country (2025-2030) & (USD Million)
 Table 86. Anti-amyloid Therapy Raw Material
 Table 87. Key Manufacturers of Anti-amyloid Therapy Raw Materials
 Table 88. Anti-amyloid Therapy Typical Distributors
 Table 89. Anti-amyloid Therapy Typical Customers


List of Figures
 Figure 1. Anti-amyloid Therapy Picture
 Figure 2. Global Anti-amyloid Therapy Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Anti-amyloid Therapy Revenue Market Share by Type in 2023
 Figure 4. Lecanemab Examples
 Figure 5. Donanemab Examples
 Figure 6. Global Anti-amyloid Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Anti-amyloid Therapy Revenue Market Share by Application in 2023
 Figure 8. Hospital Examples
 Figure 9. Clinic Examples
 Figure 10. Other Examples
 Figure 11. Global Anti-amyloid Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Anti-amyloid Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Anti-amyloid Therapy Sales Quantity (2019-2030) & (K Units)
 Figure 14. Global Anti-amyloid Therapy Price (2019-2030) & (US$/Unit)
 Figure 15. Global Anti-amyloid Therapy Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Anti-amyloid Therapy Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Anti-amyloid Therapy by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Anti-amyloid Therapy Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Anti-amyloid Therapy Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Anti-amyloid Therapy Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Anti-amyloid Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Anti-amyloid Therapy Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Anti-amyloid Therapy Average Price by Type (2019-2030) & (US$/Unit)
 Figure 30. Global Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Anti-amyloid Therapy Revenue Market Share by Application (2019-2030)
 Figure 32. Global Anti-amyloid Therapy Average Price by Application (2019-2030) & (US$/Unit)
 Figure 33. North America Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Anti-amyloid Therapy Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Anti-amyloid Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Anti-amyloid Therapy Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Anti-amyloid Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Anti-amyloid Therapy Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Anti-amyloid Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Anti-amyloid Therapy Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Anti-amyloid Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Anti-amyloid Therapy Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Anti-amyloid Therapy Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Anti-amyloid Therapy Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Anti-amyloid Therapy Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Anti-amyloid Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 73. Anti-amyloid Therapy Market Drivers
 Figure 74. Anti-amyloid Therapy Market Restraints
 Figure 75. Anti-amyloid Therapy Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Anti-amyloid Therapy in 2023
 Figure 78. Manufacturing Process Analysis of Anti-amyloid Therapy
 Figure 79. Anti-amyloid Therapy Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Eisai
Biogen
Eli Lilly

Related Reports

Global Anti-amyloid Therapy Supply, Demand and Key Producers, 2024-2030

Global Anti-amyloid Therapy Supply, Demand and Key Producers, 2024-2030

date 27 Oct 2024

date Pharma & Healthcare

Anti-amyloid therapy refers to a treatment approach aimed at addressing Alzheimer's disease by targeting and reducing the accumulation of amyloid-beta plaques in the brain. These therapies are designed to modify the disease's progression rather than merely alleviate symptoms. By utilizing agents that bind to amyloid-beta or promote its clearance, anti-amyloid therapies seek to improve cognitive function and slow neurodegeneration in affected individuals. Prominent examples include donanemab and lecanemab, which have been used to treat early stages of Alzheimer’s.

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>